NCT06730737 Lifewise Preventive Video Education in Primary Care
| NCT ID | NCT06730737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Trinity Health-Livonia |
| Condition | Prevention Harmful Effects |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2025-04-01 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is widely accepted that prevention is far more impactful than curative medicine and must be included in primary care. In a previous pilot study, we evaluated passive video preventive lifestyle education in the emergency department. The current study is a randomized prospective trial assessing the practicality and impact of a brief interactive educational video intervention to patients during primary care clinic visits.
Eligibility Criteria
Inclusion Criteria: * Adults between the ages of 18 and 80, inclusive. Exclusion Criteria: * Non-English-speaking patient * Unable or unwilling to consent to the study * Unable or unwilling to hear a video on a smartphone or computer tablet * The patient is in hospice care * Patients with advanced dementia, in the opinion of the person administering the survey
Contact & Investigator
Daniel Keyes, MD, MPH
PRINCIPAL INVESTIGATOR
Trinity Health-Livonia
Frequently Asked Questions
Who can join the NCT06730737 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Prevention Harmful Effects. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06730737 currently recruiting?
Yes, NCT06730737 is actively recruiting participants. Contact the research team at dankeyes@msu.edu for enrollment information.
Where is the NCT06730737 trial being conducted?
This trial is being conducted at Livonia, United States.
Who is sponsoring the NCT06730737 clinical trial?
NCT06730737 is sponsored by Trinity Health-Livonia. The principal investigator is Daniel Keyes, MD, MPH at Trinity Health-Livonia. The trial plans to enroll 350 participants.